• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿魏酸次甲基呋喃香豆素是一种强效的人尿苷二磷酸葡萄糖醛酸转移酶的广谱抑制剂。

Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.

机构信息

Institute of Interdisciplinary Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Key Laboratory of Biotechnology and Bioresources Utilization, Educational of Minister, College of Life Science, Dalian Minzu University, Dalian 116600, China.

Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; Dalian Medical University, Dalian 116044, China.

出版信息

Chem Biol Interact. 2018 Mar 25;284:48-55. doi: 10.1016/j.cbi.2018.02.009. Epub 2018 Feb 19.

DOI:10.1016/j.cbi.2018.02.009
PMID:29470958
Abstract

Amentoflavone (AMF), an abundant natural biflavonoid found in many medicinal plants, displays various beneficial effects including anti-inflammatory, anti-oxidative and anti-cancer. Despite the extensive studies on pharmacological activities, the toxicity or undesirable effects of AMF are rarely reported. In this study, the inhibitory effects of AMF on human UDP-glucuronosyltransferases (UGTs) were carefully investigated. AMF displayed strong inhibition towards most of human UGTs including UGT1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4 and 2B17, with the IC values ranging from 0.12 μM to 16.81 μM. Inhibition constants (K) of AMF against various human UGTs varied from 0.29 μM to 11.51 μM. Further investigation demonstrated that AMF was a noncompetitive inhibitor of UGT1A1 mediated NCHN-O-glucuronidation but functioned as a competitive inhibitor of UGT1A1 mediated 4-MU-O-glucuronidation. In addition, AMF was a competitive inhibitor of UGT1A4 mediated TFP-N-glucuronidation in both UGT1A4 and human liver microsomes, while functioned as a competitive inhibitor of UGT1A9 mediated propofol or 4-MU-O-glucuronidation. These findings demonstrated that AMF was a strong and broad-spectrum natural inhibitor of most human UGTs, which might bring potential risks of herb-drug interactions (HDIs) via UGT inhibition. Additionally, this study provided novel insights into the underlying mechanism of AMF-associated toxicity from the perspective of UGT inhibition.

摘要

银杏双黄酮(AMF)是一种在许多药用植物中含量丰富的天然二氢黄酮,具有抗炎、抗氧化和抗癌等多种有益作用。尽管对其药理学活性进行了广泛研究,但 AMF 的毒性或不良作用很少有报道。在这项研究中,我们仔细研究了 AMF 对人 UDP-葡糖醛酸基转移酶(UGTs)的抑制作用。AMF 对包括 UGT1A1、1A3、1A4、1A6、1A7、1A8、1A9、1A10、2B4 和 2B17 在内的大多数人 UGTs 显示出强烈的抑制作用,IC 值范围为 0.12 μM 至 16.81 μM。AMF 对各种人 UGTs 的抑制常数(K)从 0.29 μM 到 11.51 μM 不等。进一步的研究表明,AMF 是非竞争性抑制剂,可抑制 UGT1A1 介导的 NCHN-O-葡糖醛酸化,但作为 UGT1A1 介导的 4-MU-O-葡糖醛酸化的竞争性抑制剂。此外,在人肝微粒体和 UGT1A4 中,AMF 是 UGT1A4 介导的 TFP-N-葡糖醛酸化的竞争性抑制剂,而作为 UGT1A9 介导的丙泊酚或 4-MU-O-葡糖醛酸化的竞争性抑制剂。这些发现表明,AMF 是大多数人 UGTs 的一种强而广谱的天然抑制剂,可能通过 UGT 抑制导致草药-药物相互作用(HDIs)的潜在风险。此外,这项研究从 UGT 抑制的角度为 AMF 相关毒性的潜在机制提供了新的见解。

相似文献

1
Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.阿魏酸次甲基呋喃香豆素是一种强效的人尿苷二磷酸葡萄糖醛酸转移酶的广谱抑制剂。
Chem Biol Interact. 2018 Mar 25;284:48-55. doi: 10.1016/j.cbi.2018.02.009. Epub 2018 Feb 19.
2
Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.甘草查尔酮A对人尿苷二磷酸葡萄糖醛酸转移酶抑制潜力的评估。
Food Chem Toxicol. 2016 Apr;90:112-22. doi: 10.1016/j.fct.2016.02.007. Epub 2016 Feb 10.
3
Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.酪氨酸激酶抑制剂通过抑制尿苷二磷酸葡萄糖醛酸转移酶产生的药物相互作用潜力
Sci Rep. 2015 Dec 8;5:17778. doi: 10.1038/srep17778.
4
Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.人尿苷二磷酸葡萄糖醛酸转移酶的底物(三氟拉嗪)和抑制剂(阿米替林、雄甾酮、坎利酮酸、海柯皂苷元、保泰松、奎尼丁、奎宁和磺吡酮)“探针”的选择性。
Drug Metab Dispos. 2006 Mar;34(3):449-56. doi: 10.1124/dmd.105.007369. Epub 2005 Dec 28.
5
Cabozantinib Carries the Risk of Drug-Drug Interactions Inhibition of UDPglucuronosyltransferase (UGT) 1A9.卡博替尼存在药物-药物相互作用的风险,可抑制尿苷二磷酸葡萄糖醛酸转移酶(UGT)1A9。
Curr Drug Metab. 2022;23(11):912-919. doi: 10.2174/1389200224666221028140652.
6
Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes.通过表达的尿苷二磷酸葡萄糖醛酸基转移酶和人肝微粒体对阿司匹林代谢产物水杨酸进行葡萄糖醛酸化。
Drug Metab Dispos. 2006 Feb;34(2):199-202. doi: 10.1124/dmd.105.005652. Epub 2005 Oct 28.
7
Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions.达巴非尼对人 UDP-葡糖醛酸基转移酶的抑制作用:对药物相互作用的影响。
Biomed Chromatogr. 2021 Nov;35(11):e5205. doi: 10.1002/bmc.5205. Epub 2021 Jul 7.
8
Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferases.人尿苷二磷酸葡萄糖醛酸基转移酶对水飞蓟(水飞蓟属)中水飞蓟宾非对映异构体进行区域选择性和立体选择性葡萄糖醛酸化差异的证据。
Xenobiotica. 2011 Sep;41(9):743-51. doi: 10.3109/00498254.2011.573017. Epub 2011 Apr 27.
9
Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.阿维A对UDP-葡萄糖醛酸基转移酶(UGT)1A9介导的4-甲基伞形酮(4-MU)和丙泊酚葡萄糖醛酸化反应具有抑制作用。
Pharmazie. 2013 Jun;68(6):449-52.
10
Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.人尿苷二磷酸葡萄糖醛酸基转移酶:4-甲基伞形酮和1-萘酚葡萄糖醛酸化的同工型选择性及动力学、有机溶剂的影响以及双氯芬酸和丙磺舒的抑制作用
Drug Metab Dispos. 2004 Apr;32(4):413-23. doi: 10.1124/dmd.32.4.413.

引用本文的文献

1
Potential of amentoflavone with antiviral properties in COVID-19 treatment.具有抗病毒特性的穗花杉双黄酮在新冠病毒肺炎治疗中的潜力
Asian Biomed (Res Rev News). 2021 Aug 20;15(4):153-159. doi: 10.2478/abm-2021-0020. eCollection 2021 Aug.
2
Inhibitory effect of hieron on human cytochrome P450.希伦对人细胞色素P450的抑制作用。
Front Pharmacol. 2023 Feb 15;14:1108867. doi: 10.3389/fphar.2023.1108867. eCollection 2023.
3
Studies on Chemical Characterization of Ginkgo Amillaria Oral Solution and Its Drug-Drug Interaction With Piceatannol 3'---D-Glucopyranoside for Injection.
银杏蜜环口服溶液的化学特性及其与注射用白藜芦醇3'-O-β-D-吡喃葡萄糖苷药物相互作用的研究。
Front Pharmacol. 2022 Jul 19;13:932646. doi: 10.3389/fphar.2022.932646. eCollection 2022.
4
Biflavonoids: Important Contributions to the Health Benefits of Ginkgo ( L.).双黄酮类化合物:对银杏健康益处的重要贡献。
Plants (Basel). 2022 May 23;11(10):1381. doi: 10.3390/plants11101381.
5
Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid.杨梅素研究进展:一种天然多功能双黄酮类化合物。
Front Pharmacol. 2021 Dec 22;12:768708. doi: 10.3389/fphar.2021.768708. eCollection 2021.
6
Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole.研究药物代谢酶在达匹韦林与咪康唑药物相互作用中的作用。
Pharmaceutics. 2021 Dec 18;13(12):2193. doi: 10.3390/pharmaceutics13122193.
7
Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CL: Inhibition potentials, covalent binding sites and inhibitory mechanisms.白首乌中二氢查耳酮类化合物作为 SARS-CoV-2 3CL 的共价抑制剂:抑制潜力、共价结合位点和抑制机制。
Int J Biol Macromol. 2021 Sep 30;187:976-987. doi: 10.1016/j.ijbiomac.2021.07.167. Epub 2021 Jul 30.
8
Effects of -Cresol on Oxidative Stress, Glutathione Depletion, and Necrosis in HepaRG Cells: Comparisons to Other Uremic Toxins and the Role of -Cresol Glucuronide Formation.对甲酚对HepaRG细胞氧化应激、谷胱甘肽耗竭及坏死的影响:与其他尿毒症毒素的比较及对甲酚葡萄糖醛酸苷形成的作用
Pharmaceutics. 2021 Jun 9;13(6):857. doi: 10.3390/pharmaceutics13060857.
9
Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A against CYP2C8 and CYP2C9 Enzyme Activities in Human Liver Microsomes.双黄酮类化合物Selamariscina A对人肝微粒体中CYP2C8和CYP2C9酶活性具有强效且选择性的抑制作用。
Pharmaceutics. 2020 Apr 10;12(4):343. doi: 10.3390/pharmaceutics12040343.
10
Recent progress and challenges in screening and characterization of UGT1A1 inhibitors.UGT1A1抑制剂筛选与表征的最新进展及挑战
Acta Pharm Sin B. 2019 Mar;9(2):258-278. doi: 10.1016/j.apsb.2018.09.005. Epub 2018 Sep 14.